What is the recommended treatment for a patient with syphilis infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Syphilis Infection

Benzathine penicillin G is the definitive treatment for all stages of syphilis, with dosing determined by disease stage: a single 2.4 million unit intramuscular injection for early syphilis (primary, secondary, or early latent) and three weekly doses of 2.4 million units for late latent or tertiary syphilis. 1, 2

Treatment by Stage

Primary, Secondary, and Early Latent Syphilis

  • Administer benzathine penicillin G 2.4 million units intramuscularly as a single dose 1, 2, 3
  • Early latent syphilis is defined as infection acquired within the preceding year, documented by seroconversion, fourfold increase in titer, symptoms within the past year, or having a sex partner with documented early syphilis 1
  • This single-dose regimen is equally effective in HIV-infected patients—do not use multiple doses unless treating late-stage disease 1, 4

Late Latent Syphilis and Tertiary Syphilis

  • Administer benzathine penicillin G 2.4 million units intramuscularly once weekly for 3 consecutive weeks (total 7.2 million units) 1, 5, 2
  • Before treating tertiary syphilis, perform CSF examination to exclude neurosyphilis, as the tertiary regimen is inadequate for CNS involvement 5
  • If a dose is missed, an interval of 10-14 days between doses is acceptable before restarting the sequence 1

Neurosyphilis

  • Administer aqueous crystalline penicillin G 18-24 million units IV daily (given as 3-4 million units every 4 hours or continuous infusion) for 10-14 days 6, 1, 5
  • Alternative: procaine penicillin 2.4 million units IM once daily PLUS probenecid 500 mg orally four times daily for 10-14 days 6, 1
  • Procaine penicillin without probenecid does not achieve adequate CSF levels and must not be used 1
  • Some specialists recommend following neurosyphilis treatment with 3 weeks of benzathine penicillin 2.4 million units IM weekly, though no consensus exists 6

Penicillin-Allergic Patients

Non-Pregnant Adults

  • For early syphilis (primary, secondary, early latent): doxycycline 100 mg orally twice daily for 14 days 1, 2, 7
  • For late latent syphilis: doxycycline 100 mg orally twice daily for 28 days 1, 2, 7
  • Doxycycline has a slightly lower success rate than penicillin, particularly in late and indeterminate syphilis 8
  • Ceftriaxone 1 gram IM/IV daily for 10-14 days is a reasonable alternative based on randomized trial data showing comparable efficacy to benzathine penicillin 1
  • Do not use azithromycin in the United States due to widespread macrolide resistance and documented treatment failures 1

Pregnant Women

  • All pregnant women with penicillin allergy MUST undergo desensitization followed by penicillin treatment—no exceptions 1, 5, 2
  • Penicillin is the only therapy proven to prevent maternal transmission and treat fetal infection 1, 2
  • Tetracycline, doxycycline, erythromycin, azithromycin, and ceftriaxone are inadequate—erythromycin does not reliably cure fetal infection 1
  • Screen all pregnant women for syphilis at first prenatal visit, during third trimester, and at delivery 1

Neurosyphilis in Penicillin-Allergic Patients

  • Penicillin desensitization followed by IV penicillin is the preferred approach 6
  • Ceftriaxone 2 grams IV daily for 10-14 days has limited supporting data but may be considered if desensitization is not feasible 6, 1
  • Patients with severe penicillin allergy (Stevens-Johnson syndrome) may also be allergic to ceftriaxone as both are beta-lactam antibiotics 1

HIV-Infected Patients

  • Use the same treatment regimens as HIV-negative patients for all stages of syphilis 1, 2, 4
  • A single dose of benzathine penicillin is sufficient for early syphilis in HIV-infected patients—multiple doses do not improve outcomes 1, 4
  • Closer follow-up is mandatory to detect treatment failure or disease progression 6, 1
  • All HIV-infected patients with late latent syphilis or syphilis of unknown duration should undergo CSF examination before treatment 6
  • Some specialists recommend CSF examination for all HIV-infected patients with syphilis, regardless of stage 6

Follow-Up and Monitoring

Serologic Monitoring

  • Repeat quantitative nontreponemal tests (RPR or VDRL) at 3,6,9,12, and 24 months after treatment 6, 1
  • Expect a fourfold decline in titer within 6 months for primary/secondary syphilis and within 12-24 months for late syphilis 1, 2
  • Do not switch between RPR and VDRL when monitoring response, as results cannot be directly compared 1

Treatment Failure Criteria

  • Treatment failure is defined as: persistent or recurring clinical signs/symptoms, sustained fourfold increase in nontreponemal titers, or failure of initially high titer to decline fourfold within expected timeframes 1, 5
  • If treatment failure occurs, re-evaluate for HIV infection, perform CSF examination, and re-treat with three weekly injections of benzathine penicillin G 2.4 million units IM unless neurosyphilis is diagnosed 1, 5
  • 15-25% of successfully treated patients remain "serofast" with persistent low titers (<1:8) that do not indicate treatment failure 1

Management of Sex Partners

  • Treat sex partners presumptively if exposed within 90 days preceding diagnosis of primary, secondary, or early latent syphilis, even if seronegative 1, 2
  • Time periods for at-risk partners: 3 months plus duration of symptoms for primary syphilis, 6 months plus duration of symptoms for secondary syphilis, and 1 year for early latent syphilis 1
  • Long-term sex partners of patients with late syphilis should be evaluated clinically and serologically 2

Critical Pitfalls to Avoid

  • Do not use oral penicillin preparations—they are completely ineffective for any stage of syphilis 1, 5
  • Do not skip CSF examination before treating tertiary syphilis, as this may miss neurosyphilis requiring different treatment 5
  • Do not use procaine penicillin without probenecid for neurosyphilis—it does not achieve adequate CSF levels 1
  • Do not substitute non-penicillin antibiotics in pregnancy without desensitization 1, 5
  • Warn patients about Jarisch-Herxheimer reaction, an acute febrile reaction with headache and myalgia that may occur within 24 hours of treatment, especially in early syphilis 1, 5
  • In pregnant women treated during the second half of pregnancy, Jarisch-Herxheimer reaction may precipitate premature labor or fetal distress—advise immediate medical attention if contractions or changes in fetal movements occur 1

Special Considerations

Pediatric Dosing

  • For children with acquired primary or secondary syphilis: benzathine penicillin G 50,000 units/kg IM, up to the adult dose of 2.4 million units in a single dose 1, 2
  • For late latent syphilis in children: benzathine penicillin G 50,000 units/kg IM, up to the adult dose of 2.4 million units, for three total doses at 1-week intervals 1
  • Children require CSF examination to exclude neurosyphilis before treatment 1

All Patients

  • Test all patients with syphilis for HIV infection 1
  • Patients with syphilis should be evaluated for clinical evidence of CNS or ocular involvement regardless of disease stage 6

References

Guideline

Syphilis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Syphilis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Syphilis: A Review.

JAMA, 2025

Research

Single Dose Versus 3 Doses of Intramuscular Benzathine Penicillin for Early Syphilis in HIV: A Randomized Clinical Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017

Guideline

Treatment for Stage 3 (Tertiary) Syphilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.